Perclose device successful in first human trial:
This article was originally published in Clinica
Perclose claims that initial human clinical testing of its automated device for suturing blood vessels during conventional or minimally invasive coronary artery bypass surgery has shown promising results. The Menlo Park, California-based company said that by automating the delivery of 10 needles and sutures to the coronary artery and saphenous vein, its Heartflo system provided a precise, consistent and repeatable suture pattern. An automated suturing approach is expected to be particularly important during minimally invasive cardiac surgery where surgeons have to work through small incisions in the chest, often on a beating heart.